Critical roles of the TGF-β type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development  by Matsunobu, Tomoya et al.
Developmental Biology 332 (2009) 325–338
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyCritical roles of the TGF-β type I receptor ALK5 in perichondrial formation
and function, cartilage integrity, and osteoblast differentiation during growth
plate development
Tomoya Matsunobu a,b, Kiyoyuki Torigoe a,b, Masaki Ishikawa a, Susana de Vega a, Ashok B. Kulkarni a,
Yukihide Iwamoto b, Yoshihiko Yamada a,⁎
a Laboratory of Cell and Developmental Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA
b Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan⁎ Corresponding author. Bldg. 30, Rm. 407, NIDCR, NIH
Bethesda, MD 20892-4370, USA. Fax: +1 301 402 0897.
E-mail address: yoshi.yamada@nih.gov (Y. Yamada).
0012-1606/$ – see front matter. Published by Elsevier I
doi:10.1016/j.ydbio.2009.06.002a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 24 December 2008
Revised 31 May 2009
Accepted 1 June 2009
Available online 6 June 2009
Keywords:
ALK5 (TGF-β type I receptor)
Skeletal progenitor cells
Osteoblasts
Chondrocytes
Growth plate
Perichondrium
Conditional knockout miceTGF-β has been implicated in the proliferation and differentiation of chondrocytes and osteoblasts. However,
the in vivo function of TGF-β in skeletal development is unclear. In this study, we investigated the role of TGF-
β signaling in growth plate development by creating mice with a conditional knockout of the TGF-β type I
receptor ALK5 (ALK5CKO) in skeletal progenitor cells using Dermo1-Cre mice. ALK5CKO mice had short and
wide long bones, reduced bone collars, and trabecular bones. In ALK5CKO growth plates, chondrocytes
proliferated and differentiated, but ectopic cartilaginous tissues protruded into the perichondrium. In normal
growth plates, ALK5 protein was strongly expressed in perichondrial progenitor cells for osteoblasts, and in a
thin chondrocyte layer located adjacent to the perichondrium in the peripheral cartilage. ALK5CKO growth
plates had an abnormally thin perichondrial cell layer and reduced proliferation and differentiation of
osteoblasts. These defects in the perichondrium likely caused the short bones and ectopic cartilaginous
protrusions. Using tamoxifen-inducible Cre-ER™-mediated ALK5-deﬁcient primary calvarial cell cultures, we
found that TGF-β signaling promoted osteoprogenitor proliferation, early differentiation, and commitment to
the osteoblastic lineage through the selective MAPKs and Smad2/3 pathways. These results demonstrate the
important roles of TGF-β signaling in perichondrium formation and differentiation, as well as in growth plate
integrity during skeletal development.Published by Elsevier Inc.IntroductionEndochondral and intramembranous ossiﬁcations are two major
processes that control skeletogenesis. In endochondral ossiﬁcation,
precursor mesenchymal cells condense in the areas destined to
become bone and differentiate into chondrocytes. Differentiated
chondrocytes proliferate and undergo further differentiation pro-
cesses to mature hypertrophic chondrocytes that subsequently are
replaced by bone cells (Kronenberg, 2003). Mesenchymal cells at the
periphery of the condensation give rise to the perichondrium, which
differentiates into osteoblasts and forms a bone collar. The perichon-
drium consists of the outer ﬁbrous layer and inner osteoprogenitor
cell layer (Kronenberg, 2003). In intramembranous ossiﬁcation,
condensed mesenchymal cells directly differentiate into osteoblasts
and form bone (Nakashima and de Crombrugghe, 2003).
Transforming growth factor-β (TGF-β) and its related factors,
including bone morphogenetic proteins (BMPs) and activins, regulate
diverse cellular processes, such as proliferation, differentiation,, 30 Convent Drive MSC 4370,
nc.apoptosis, and extracellular matrix formation during embryogenesis.
TGF-β signaling is mediated by two types of transmembrane serine/
threonine kinase receptors, type I (ALK5) and type II receptors, which
form a heteromeric complex. In this signaling complex, following TGF-
β binding to the type II receptor (TGFβRII), the type II receptor
phosphorylates and activates ALK5. Activated ALK5 then induces
signaling cascades through Smad-dependent and Smad-independent
pathways. In the Smad-dependent pathway, the TGF-β-receptor
complex activates Smad2/3, whereas the BMP-receptor complex
activates Smad1/5/8 (Feng and Derynck, 2005).
TGF-β signaling has been implicated in cartilage and bone
formation in a number of studies. However, this conclusion is
controversial, in part because of multiple signaling cascades and
redundant expression of three TGF-β isoforms (TGF-β1, -β2 and -β3).
Genetic manipulations of TGF-β signaling molecules in mice have
clariﬁed some of their roles in skeletogenesis. However, since gene
targeting of TGF-β signaling molecules has resulted in variable
phenotypes, ranging from early embryonic lethality to normal
phenotype at birth, the precise role of TGF-β signaling in skeletal
development is not yet fully understood. For example, targeted
germline deletions of Tgfbr2 and Alk5 result in early embryonic
lethality because of defects in hematopoiesis and vasculogenesis
326 T. Matsunobu et al. / Developmental Biology 332 (2009) 325–338before skeletal elements are formed (Larsson et al., 2001; Oshima
et al., 1996). In contrast, Col2a1-Cre-mediated conditional inactiva-
tion of Tgfbr2 in chondrocytes does not show obvious defects in long
bone formation (Bafﬁ et al., 2004), while Prx1-Cre-mediated Tgfbr2
deletion in the limb mesenchyme results in short limbs and fusion of
the joints of the phalanges (Seo and Serra, 2007; Spagnoli et al.,
2007). A genetic deletion of Smad3, a known substrate for ALK5 and
an important mediator of the canonical Smad-dependent pathway,
displays normal phenotype at birth (Borton et al., 2001), suggesting
that the TGF-β-Smad2/3 signaling may not be required for limb
development. On the other hand, mice deﬁcient in TGF-β2 suffer
perinatal lethality with abnormal skeletal formation, such as
reduced cranial ossiﬁcation, bifurcation of the sternum, irregular
and fused ribs, and shortened limbs (Sanford et al., 1997), suggesting
that TGF-β signaling is indispensable for skeletogenesis.
ALK5 is one of themost prominent receptors for TGF-β superfamily
members in skeletal tissues. Recent studies suggest that ALK5 may
also serve as a receptor for some other TGF-β superfamily proteins,
such as myostatin (GDF8) and GDF11(Andersson et al., 2006;
Rebbapragada et al., 2003; Tsuchida et al., 2008; Wu et al., 2003).
Deﬁciency of ALK5 should eliminate Smad-dependent and Smad-
independent signaling for all TGF-β isoforms and other potential TGF-
β superfamily proteins. In the present study, conditional knockout
mice have been created in which ALK5 was inactivated in skeletal
progenitor cells by Dermo1-Cre expression in mice and tamoxifen-
inducible Cre-ER™ expression in vitro. This allowed us to circumvent
the early embryonic lethality observed in a germline of ALK5-null
mice (Larsson et al., 2001) in order to investigate the role of ALK5 in
skeletogenesis. We demonstrated that ALK5 is expressed in the
skeletal primordium and that Dermo1-Cre-mediated ALK5 conditional
knockout (ALK5CKO) results in bone growth retardation, defects in
perichondrium, and abnormal cartilaginous protrusions. Our studies
indicate that ALK5 regulates the commitment of progenitor cells to the
osteoblastic lineage, followed by osteoblast proliferation and differ-
entiation through selective downstream pathways.
Materials and methods
Mouse lines
ALK5-ﬂoxed (Alk5ﬂox/ﬂox) mice and Dermo1-Cre knock-in mice
were kindly provided by Dr. Stefan Karlsson (Department of Molecular
Medicine and Gene Therapy. Institute of Laboratory Medicine, Lund
University Hospital, Lund, Sweden) (Larsson et al., 2003) and Dr.
David M. Ornitz (Department of Molecular Biology and Pharmacology,
Washington University Medical School, St. Louis, MI) (Yu et al., 2003),
respectively. Skeletal progenitor-speciﬁc ALK5 conditional knockout
ALK5CKO (Alk5ﬂox/ﬂox; Dermo1Cre/wt) mice were created by crossing
Alk5ﬂox/ﬂox homozygous females with Alk5ﬂox/wt; Dermo1Cre/wt double
heterozygous males. ROSA26 Cre-reporter mice were created by Dr.
Philippe Soriano's laboratory (Fred Hutchinson Cancer Research
Center, Seattle, Washington) (Soriano, 1999) and obtained from
Jackson Labs (Bar Harbor, ME). The ROSA26 promoter confers
ubiquitous expression of LacZ. Rosa26 mice were crossed with
Dermo1-Cre mice to create Dermo1Cre/WT; Rosa26 mice to trace
Dermo1 expression. A Cre-ER™ mouse line (CAGG-Cre-ER™) created
by Drs. Hayashi and McMahon (Harvard University, Cambridge, MA)
(Hayashi and McMahon, 2002) was obtained from Jackson Labs. In
Cre-ER™ mice, Cre recombinase is fused to the modiﬁed mouse
estrogen receptor ER™ under the control of the chicken β-actin
promoter and cytomegalovirus (CMV) enhancer, and Cre activity can
be induced by tamoxifen. These two lines were crossed and double
homozygous (Rosa26; Cre-ER™) mice generated. The double homo-
zygous mice were crossed with ALK5-ﬂoxed mice to generate
tamoxifen-inducible ALK5-deﬁcient mice (ALK5-Cre-ER, Alk5ﬂox/ﬂox;
Rosa26; Cre-ER™). CreER-negative Alk5ﬂox/ﬂox and wild type micewere used to prepare control calvarial cells. The animal protocol
approved by the NIDCR ACU Committee was used for maintaining and
handling mice, and all animals were housed in an American
Association for the Accreditation of Laboratory Animal Care-accredited
mouse facility.
Reagents and chemicals
TGF-β2 and BMP-2 were obtained from R & D systems (Minnea-
polis, MN). SB203580, U0126 and SP600125 were purchased from
Tocris Bioscience (Ellisville, MO). SIS3 was purchased from EMD
Bioscience (La Jolla, CA). The enhanced chemiluminescent (ECL)
blotting detection reagents were purchased from Amersham Bios-
ciences Corp. (Piscataway, NJ). Tamoxifen and Oil Red O were
purchased from Sigma, and Nile Red from Invitrogen.
Skeletal preparation
Embryos were dissected, ﬁxed in 100% ethanol overnight, and then
stained with Alcian blue, followed by Alizarin Red S, according to
standard protocols (McLeod, 1980).
Metatarsal explant culture
Metatarsal rudiments were cultured as previously described
(Haaijman et al., 1999). Metatarsal rudiments were dissected from
embryos at E15.5 and cultured in α-minimum essential medium
without nucleosides (Invitrogen) supplemented with 0.05 mg/mL
ascorbic acid (Sigma), 0.05 mg/mL gentamycin (Invitrogen), 1 mM β-
glycerophosphate (Sigma), and 0.2% FBS in a humidiﬁed atmosphere
of 5% CO2 in air at 37 °C. One day after starting the culture, the
rudiments were incubated in 400 μL of the same medium containing
10 ng/mL of TGF-β2 (R & D), or without TGF-β2, for an additional
4 days. The explants were cultured with BrdU (bromodeoxyuridine;
10 μM) for 2.5 h at the fourth day of the culture. Stereomicroscopic
photographs using Zeiss Stemi and NIH Image J software were used to
measure the length of cultured explants that had been processed for
histological examinations.
BrdU staining
Pregnant mice bearing E18.5 embryos were intraperitoneally
injected with BrdU labeling reagent (10 μL/g body weight; Zymed
Laboratories). The mice were euthanized for BrdU staining 2 h later.
Metatarsal explants were cultured with BrdU (10 μM) for 2 h at day 5.
The explants were ﬁxed in paraformaldehyde at 4 °C overnight,
embedded in parafﬁn, and cut into 5-μm sections. Incorporated BrdU
was detected using a BrdU staining kit (Invitrogen).
Isolation of calvarial cells (osteoblast-enriched cells)
Calvaria of newborn ALK5-CreER mice (Alk5ﬂox/ﬂox; Rosa26; Cre-
ER™) and CreER-negative Alk5ﬂox/ﬂox and wild type mice were
incubated six times for 10 min (for a total of 1 h) with 0.1% collagenase,
type 1 (Worthington, Lakewood, NJ) and 0.2% dispase II (Roche Applied
Science, Indianapolis, IN) in phosphate-buffered saline solution (PBS).
The last two fractions were centrifuged at 1500 rpm for 5 min,
resuspended in culture medium consisting of α-minimum essential
medium (Invitrogen, Rockville, MD) with 10% fetal bovine serum
(HyClone, Logan, UT), 100 U/mL of penicillin and 100 μg/mL of
streptomycin. For cell proliferation assays, cells were seeded at a low
density (2500 cells/cm2). The next day, cells were treated with 1 μM
tamoxifen, and allowed to proliferate for an additional 3 days in the
presence of TGF-β2 or inhibitors. For differentiation assays, cells were
seeded at a higher density (25,000/cm2). Similarly to the proliferation
assay, on the following day cells were treated with tamoxifen and
Fig. 1. Expression patterns of ALK5 protein in normal E18.5 knee joint. (A) Sagittal
section of E18.5 knee joint. The boxed area is enlarged in (B). (C–F) Transverse
sections of E18.5 femur. Panels C–F correspond to bone marrows, hypertrophic
chondrocytes, proliferating chondrocytes, and resting chondrocytes (epichondyle),
respectively. ALK5 protein was expressed in the perichondrium, synovium, ligaments,
and resting and hypertrophic chondrocytes. f, femur; t, tibia. Red arrows, Ranvier's
ossiﬁcation groove; arrow, posterior cruciate ligament; arrowhead, synovium. Bars,
100 μm. (G) Expression of ALK5 in normal E14.5 calvarial primordium. Arrows, frontal
bone. Bar, 200 μm.
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and 5 mM β-glycerophosphate. To test the reactivity of the calvarial
cells to TGF-β2 during differentiation, cells were brieﬂy exposed to TGF-
β2 (1 ng/mL) for 1 h just before cells were collected; the lysate was
subjected to Western blot analysis using phospho-Smad2 speciﬁc
antibody. Alkaline phosphatase staining was carried out using Fast Red
Violet LB salt as the diazonium salt.
Alizarin Red S staining
Primary calvarial cells were ﬁxedwith 60% isopropanol and stained
with 1% (w/v) Alizarin Red S (Sigma). After washing 5 times with PBS,
cultures were photographed and calcium depositionwas quantiﬁed by
extracting the Alizarin Red S stain with 10% cetylpyridinium chloride
(Sigma) and measuring the OD at 550 nm.
Nile Red and Oil Red O staining
Primary calvarial cells were ﬁxed for 10 min with 4% paraformal-
dehyde in PBS. After washing with PBS, they were incubated for 5 min
with either 0.1 μg/mL Nile Red in PBS or 0.3% Oil Red O. For
quantiﬁcations of Nile Red-positive areas, after 14 day culture, seven
different ﬁelds (10×) per well were randomly chosen and photo-
graphed. Images were captured using Adobe Photoshop CS (Adobe
Systems, San Jose, CA), a threshold was set to automatically compute
the area positive for the staining, and the datawere imported as a TIFF
ﬁle into NIH Image J software (National Institutes of Health, Bethesda,
MD). All experiments were repeated in triplicate.
Western blot analysis
Western blot analysis and cell extract preparationwere carried out
as previously described (Matsunobu et al., 2006). The antibodies used
were as follows: mouse polyclonal anti-TGF-βRI (Abnova, Taiwan),
rabbit polyclonal anti-MAPK, anti-phospho-MAPK (Thr202/Tyr204),
anti-p38, anti-phospho-p38 MAP Kinase (Thr180/Tyr182), anti-
SAPK/JNK, anti-phospho-SAPK/JNK (Thr183/Tyr185), anti-Smad2,
rabbit monoclonal anti-phospho-Smad2 (Ser465/467) (Cell Signal-
ing, Danvers, MA), and mouse anti-α-tubulin (Sigma, St. Louis, MO).
Horseradish peroxidase (HRP)-conjugated goat anti-mouse and goat
anti-rabbit IgG were obtained from US Biological (Swampscott, MA).
α-tubulin was used as a loading control.
Immunohistochemistry and immunoﬂuorescence
Tissue slides were deparafﬁnized using xylene and rehydrated
through an alcohol gradient series to water. Antigens were retrieved
by microwave treatment for 20 min in citrate buffer (pH 6.0).
Endogenous peroxidase enzyme activity was blocked using 3%
hydrogen peroxidase in methanol for 10 min at room temperature.
The slides were washed in distilled water and in PBS, and then
incubated overnight at 4 °C with the primary antibodies: rabbit
polyclonal anti-TGF-βRI 1:50 (Abcam, Cambridge, MA), rabbit poly-
clonal anti-Sp7/osterix 1:100 (Abcam), goat polyclonal anti-osteo-
calcin 1:100 (Biomedical Technologies, Stoughton, MA), rabbit
polyclonal anti-osteopontin 1:50 (Ogbureke and Fisher, 2004), and
mouse monoclonal anti-aggrecan (University of Iowa Hybridoma
Bank). The incubation of the slides with primary antibodies was
followed by chromogenic visualizationwith the SuperPicTure polymer
detection kit (Invitrogen) or ﬂuorescence visualization with the
appropriate secondary antibodies.
Real-time quantitative RT-PCR
DNase-free RNA was prepared using Trizol reagent (Invitrogen)
according to the manufacturer's instructions. After DNase treatment,RNA was reverse-transcribed to cDNA using the SuperscriptIII kit
(Invitrogen) according to the manufacturer's instructions. The cDNA
was subjected to real-time PCR using SYBR Green PCR Master Mix
(Bio-Rad) with DNA Engine Chromo 4 Real-time System (MJ Research,
Waltham, MA). Primer sequences and PCR conditions are described in
Supplemental Table S1. Gene expression was normalized to Ppia.
Reactions were run in triplicate.
Results
ALK5 is expressed in developing limbs and calvaria
Immunostaining of ALK5 was carried out to examine the expres-
sion of ALK5 protein in normal developing limbs (Fig. 1). In E18.5
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chondrocytes. ALK5 was also strongly expressed in a thin chondrocyte
layer at the periphery of cartilage located adjacent to the perichon-
drium (Fig. 3F′, arrows, and Supplemental Fig. S3). Expression was
also notedwithin the perichondriumwith the highest level seen at the
ossiﬁcation groove of Ranvier (Figs. 1A, E, red arrows). The ALK5
expression in the perichondrium diminished toward the center of
diaphyses where osteoblasts were differentiated (Figs. 1A, C). ALK5
expression was also observed in synovial tissues and ligaments
(Figs. 1A, B, arrowhead and white arrow, respectively), and in E14.5
calvarial primordium (Fig. 1G).
ALK5 is required for skeletogenesis and body wall formation
To determine the role of TGF-β signaling during skeletogenesis,
Alk5ﬂox/ﬂox homozygous females were crossed with Alk5ﬂox/wt;
Dermo1Cre/wt double heterozygous males, creating skeletal pro-
genitor-speciﬁc ALK5 conditional knockout ALK5CKO (Alk5ﬂox/ﬂox;
Dermo1Cre/wt) mice. Dermo1-Cre expression starts as early as
embryonic day (E) 9.5, and mesenchyme-speciﬁc expression was
observed in the limb buds, craniofacial mesenchyme and body wall
of E10.5 Dermo1Cre/wt; Rosa26 mice (Supplemental Fig. S1) (Soriano,
1999; Yu et al., 2003). Analysis of E17.5 hindlimbs of Dermo1Cre/wt;
Rosa26 reporter mice revealed positive X-gal staining in theFig. 2. Skeletal abnormalities of ALK5CKO (Alk5ﬂox/ﬂox; Dermo1Cre/wt) mice. (A) Macroscopic
developed short-limbed dwarﬁsmwith midline-fusion defect. (B, C) Skeletal preparations of
at E18.5. (C′) Higher magniﬁcation of the boxed area shown in (C). Cartilage was stained
eccentric mineralization of tibia; open arrowheads, ectopic cartilaginous protrusion. (D)
embryos at E16.5.chondrocytes in growth plate cartilage, perichondrial cells, ligament
cells, and synovial cells (Supplemental Fig. S2). Double-heterozygous
mice, Alk5ﬂox/wt; Dermo1Cre/wt, used as littermate controls in this
study, showed no apparent defects or embryonic lethality, and these
mice were viable and fertile. ALK5CKO embryos had hydramnion and
most of them died shortly after birth, possibly because of respiratory
distress due to severe midline-fusion defects. ALK5CKO embryos
developed dwarﬁsm, characterized by shorter limbs, and most of the
visceral organs such as the heart, liver, and intestine were herniated
through a body wall defect and covered with a thin and transparent
membrane (Fig. 2A). The defect in the body wall formation in
ALK5CKO embryos became obvious from E12.5 and was conspicuously
earlier than the limb abnormality during embryogenesis (data not
shown). E15.5 ALK5CKO embryos also exhibited hypoplastic skull
bases (Fig. 2A). Calvarial bone formation was severely defective in
ALK5CKO mice, and the facial bones of mutant embryos were smaller
than those of control embryos (Fig. 2A).
Skeletal preparations of E18.5 ALK5CKO mice stained with Alcian
blue and Alizarin Red S revealed that the cranial vault developed poor
ossiﬁcation and that the clavicle was shorter (Figs. 2B, D). ALK5 was
therefore important for intramembranous ossiﬁcation during embry-
ogenesis. All bones formed through endochondral ossiﬁcation were
also short and malformed (Figs. 2B, C). In the axial skeletal system,
mutantmice had a shortened body axis and developed severe scoliosislateral views of control (left) and ALK5CKO (right) embryos at E15.5. ALK5CKO embryos
whole embryos (B) and hindlimbs (C) from control (left) and ALK5CKO (right) embryos
by Alcian blue and bone was stained by Alizarin Red S. Arrow, knee joint; arrowhead,
Skeletal preparation of clavicles from littermate control (top) and ALK5CKO (bottom)
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Mutant rib cages were abnormally straight rather than curved. In
ALK5CKO mice, the sternum was formed, but failed to fuse. The
appendicular skeletal system in ALK5CKO embryos was also severely
impaired (Fig. 2C). The E16.5 ALK5CKO mice had short femurs and two
distinct, but incomplete, elements of zeugopods, inwhich ﬁbulaewere
mineralized but short and curved, whereas tibiae were not miner-
alized (data not shown). At E18.5, instead of forming a central bone
shaft, tibiae of mutant embryos had eccentric hypertrophic chon-
drocytes with an ossiﬁed bone collar (Fig. 2C′, arrowhead), while
ﬁbulae bent sharply, and a distinct knee joint space was not clearFig. 3. Thin perichondrium layer and ectopic cartilaginous protrusion in ALK5CKO growth p
hindlimbs of control (A and B) and ALK5CKO embryos (C and D) stained with H-E. The trans
hypertrophic chondrocytes in the distal femur. ALK5CKO mice exhibited partial knee join
chondrocytes in tibiae with thin perichondrium. Arrows, knee joint; arrowheads, ectopic ca
ALK5 (red) and aggrecan (green) of E17.5 control (E) and ALK5CKO hip joints (G). Arrowhea
aggrecan (green) with DAPI nuclear staining of E18.5 control (F) and ALK5CKO femur (H). T
expressionwas diminished, especially in the perichondrium, and ectopic cartilaginous protru
periphery of cartilage. Bar, 100 μm. (I, J) Coronal sections of E18.5 control (I) and ALK5CKO he
200 μm.(Fig. 2C′, arrow). Ectopic cartilaginous protrusions in pelvis, femurs
and zeugopods were noticeable and some protrusions in proximal
metaphyses of femurs extended to the mineralized diaphyses (Fig. 2C′,
open arrowheads).
ALK5 is required for joint development and perichondrium formation
To characterize the skeletal abnormalities in more detail, histolo-
gical analysis was performed (Fig. 3). E18.5 ALK5CKO embryos
developed partial knee joint fusion at the peripheral region (Fig. 3C,
arrows). Although long bones were shorter in length and wider,lates. (A–D) Histological sagittal (A and C) and transverse sections (B and D) of E18.5
verse sections are at the level of the boundary between proliferative chondrocytes and
t fusion, ectopic cartilaginous protrusions and eccentric hypertrophic maturation of
rtilaginous protrusions. f, femur; t, tibia; p, patella. (E–H) Double immunostaining for
ds, ectopic cartilaginous protrusions. (F, H) Double immunostaining for ALK5 (red) and
he boxed areas in (F) and (H) are enlarged in (F′) and (H′), respectively. ALK5 protein
sions were formed. White arrows indicate ALK5-expressing chondrocytes located at the
ads (J) stained with H-E. Calvaria of ALK5CKO mice were very thin. Arrows, calvaria. Bar,
330 T. Matsunobu et al. / Developmental Biology 332 (2009) 325–338compared to those of control mice, the three principal layers of
chondrocytes, consisting of resting, proliferative, and hypertrophic
zones, were formed in ALK5CKO femurs (Fig. 3C). The E18.5 ALK5CKO
femurs also developed ectopic cartilaginous protrusions (Fig. 3C,
arrowhead) and thin perichondrium, in which ﬁbrous and osteopro-
genitor layers were thinner and contained fewer and smaller cells
(Figs. 3C, D and Supplemental Fig. S5).
The abolishment of ALK5 expression in ALK5CKO mice was
conﬁrmed by immunostaining for ALK5 (red). Strong expression of
ALK5 was observed in the perichondrium in control mice (Figs. 3E, F),
as shown in Fig. 1. Double immunostaining with aggrecan (green), a
marker of chondrocytes, distinguished the perichondrium and
cartilage. We found the presence of a thin chondrocyte layer, which
was positive for both ALK5 and aggrecan, in the peripheral cartilage
adjacent to the perichondrial layer (Fig. 3F′, arrows). This ALK5-
expressing chondrocyte layer also stained positively for Sox9, another
chondrocyte marker (Supplemental Fig. S3). The expression of ALK5
protein was substantially diminished in ALK5CKO femurs (Figs. 3G, H,
H′) and in calvaria (data not shown). Some signals observed in
ALK5CKO skeletons (Fig. 3G) may have been produced by cells
escaping from Dermo1-Cre-mediated recombination, since some X-
gal-negative chondrocytes were found in the femurs in Dermo1Cre/wt;
Rosa26 reporter mice (Supplemental Fig. S2). Therefore, some cells
that escaped from the recombination probably also expressed ALK5
protein in the ALK5CKO mice.
Pathological changes were observed in the skeletal tissues of
ALK5CKO mice in which endogenous expression of ALK5 had been
abolished. In ALK5CKO hindlimbs, strong ALK5 expression in the
perichondrium was eradicated and formation of the perichondrium
was impaired (Fig. 3, Supplemental Figs. S4, S5). It is interesting to
note that ectopic cartilaginous protrusions were most typically
formed from the cartilage at the level of the ossiﬁcation groove of
Ranvier (Shapiro et al., 1977), where ALK5 protein expression was
strong in control mice but abolished in ALK5CKO mice (Figs. 3C, G,
arrowheads). The perichondrium surrounding the ectopic protrusion
was very thin (Supplemental Fig. S4). Moreover, serial transverse
sections of mutant femurs revealed the formation of multiple
protrusions, as well as solitary ectopic cartilage (Supplemental Fig.
S4, asterisks and arrowhead). Calvaria of E18.5 ALK5CKO heads were
thinner than those of control mice, similar to the defect observed in
the perichondrium (Figs. 3I, J).
ALK5 is required for perichondrial cell proliferation and differentiation
To characterize the perichondrium of ALK5CKO growth plates, the
proliferation activity of perichondrial cells was examined by BrdU
incorporation. Proliferation of perichondrial cells was markedly
reduced in E18.5 ALK5CKO femurs (Fig. 4A). In contrast to these
observations for perichondrial cells, the proliferation activity of
chondrocytes at the base of the protrusion increased (Fig. 4B). These
data suggest that the abnormally thin perichondrium and enhanced
proliferation activity of chondrocytes in the periphery of cartilagemay
account, at least in part, for the formation of the ectopic cartilaginous
protrusions.
Cartilage- and bone-mineralization were next examined in
hindlimbs by expression analysis of bone-speciﬁc proteins as
differentiation markers. In E11.5 control limb buds, Runx2, a master
regulator of osteoblast differentiation, was expressed in mesenchymal
condensation, while the expression in ALK5CKO limb buds was
signiﬁcantly decreased (Fig. 4C). Staining with von Kossa/safranin-O
showed less calciﬁed cartilage and bone matrix in E18.5 ALK5CKO
femurs. Mineralization, especially in the bone collar, was also
signiﬁcantly reduced (Fig. 4D).
Osterix is an osteoblast-speciﬁc transcription factor and a marker
for early osteoblast differentiation (Nakashima et al., 2002). In control
femurs, osterix-positive cells lined the perichondrium, as well as thesurface of the trabecular bone in the bone marrow (Fig. 4D). On the
other hand, these areas of ALK5CKO femurs had less osterix-positive
cells. Osteopontin and osteocalcin, which are bone matrix proteins
and late differentiation markers, respectively, were expressed in
control femurs, whereas their expression levels were substantially
lower in ALK5CKO femurs (Fig. 4D). Their expression levels were also
markedly reduced in the bone collar. These data suggest that an ALK5
deﬁciency in skeletal progenitor cells at the early stage of skeletogen-
esis caused the inhibition of osteoblast proliferation and maturation
observed in limbs.
ALK5 regulates calvarial cell proliferation and differentiation
Primary neonatal calvarial cells were used to obtain a better
understanding of the mechanism of ALK5 functions in osteoblast
proliferation and differentiation. Since bone formation of ALK5CKO was
poor, sufﬁcient cell numbers could not be obtained from ALK5CKO
calvaria. Therefore, a tamoxifen-inducible Cre mouse line (Cre-ER™)
was employed in place of the Dermo1-Cre mouse line to allow
preparation of sufﬁcient number of primary cells. Cre-ER™mice were
crossed with Rosa26 reporter mice (Soriano, 1999) to enable the
tracking and visualization of Cre-mediated inactivation of ALK5. By
cross-mating Alk5ﬂox/ﬂox mice with those mice, tamoxifen-inducible
ALK5 deﬁcient mice (ALK5/Cre-ER, Alk5ﬂox/ﬂox; Rosa26; Cre-ER™)
were created that were able to provide sufﬁcient calvarial cells from
neonates.We also prepared CreER-negative control calvarial cells from
Alk5ﬂox/ﬂox and wild type mice.
First, the proliferative activity of calvarial cells was examined, as
shown in the scheme presented in Fig. 5D. After a 3-day treatment
with tamoxifen, the cell number was reduced by 40% (Fig. 5A).
Addition of TGF-β2 increased the cell number in the absence of
tamoxifen, but not in the presence of tamoxifen (Fig. 5A). This
indicated that TGF-β signaling promoted proliferation of control
calvarial cells through ALK5, but not in tamoxifen-treated cells. For
analysis of cell differentiation, calvarial cells were cultured at a higher
density in the osteogenic medium to induce osteoblast differentiation.
Alkaline phosphatase (ALP) activity, an early osteoblast differentiation
marker, was then analyzed as shown in Fig. 5D. ALP was not expressed
at day 0 of the induction (data not shown) but had been induced by
3 days after osteoinduction in control cells. In tamoxifen-treated cells,
ALP activity was reduced (Fig. 5B, right panel). Tamoxifen-induced
ALK5 inactivation was also visualized by X-gal staining of calvarial
cells from ALK5/Cre-ER/ROSA26 mice (Fig. 5B, left panel) and
conﬁrmed by deleted allele-speciﬁc genomic PCR (data not shown).
The double staining of X-gal and ALP revealed the striking ﬁnding that
X-gal-positive cells showed little ALP activity (Fig. 5B). These data
suggest that TGF-β signaling is important in the early differentiation
of osteoblasts.
In the mineralization assay, using Alizarin Red S staining for
terminal differentiation of osteoblasts, calvarial cells were treated in
the same manner as for the ALP assay, except that cells were
analyzed at 17 days after osteoinduction (Fig. 5C, left pictures), and
the staining for Alizarin Red S was quantiﬁed (Fig. 5C, right graph).
The cells cultured with tamoxifen were less mineralized than the
control cells cultured without tamoxifen. When TGF-β2 was included
in the culture at osteoinduction initiation, complete inhibition of
mineralization was observed. However, TGF-β2 failed to inhibit
mineralization in ALK5 deﬁcient cells induced by tamoxifen (Fig. 5C).
The maturation defect observed when ALK5 inactivation was induced
at the early osteoinduction condition (Fig. 5D) was caused by the
early differentiation defect (Fig. 5B). When cells were treated with
tamoxifen at 4 days or later after osteoinduction, no mineralization
defect was observed (data not shown). In control experiments, we
tested the effect of tamoxifen on proliferation, ALP activity, and
mineralization of calvarial cells from wild type and Alk5ﬂox/ﬂox mice.
Tamoxifen did not affect these activities in wild type calvarial cells or
Fig. 4. Reduced proliferation and differentiation of the perichondrium and osteoprogenitor cells in ALK5CKO mice. (A) (Left) BrdU staining of the distal end of femurs at E18.5. Higher
magniﬁcations of the boxed areas in panels A1 and A2 are shown in A1′ and A2′, respectively. (Right) The number of BrdU-labeled cells in perichondriumwas quantiﬁed. Proliferation
activity of perichondrial cells was markedly reduced in ALK5CKO femurs. pc, perichondrium. Bar, 100 μm. (B) BrdU staining (green) of the proximal end of E17.5 ALK5CKO femur. Higher
magniﬁcation of the boxed area is shown in panel B′. Note that contrary to perichondrial cells, proliferation activity of chondrocytes at the base of the protrusion was increased. Bar,
100 μm. (C)Whole mount in situ hybridization of runx2 at E11.5 in control and ALK5CKO embryos. Lower panels showmagniﬁed lateral view of hindlimbs in panel C. Runx2 expression
wasdecreased in limbbudsofALK5CKO embryos. (D) vonKossa andsafranin-O staining, and immunostainingwith antibodies to osterix, osteopontin, andosteocalcin.Mineralization and
expression of osteoblast markers for early and late differentiation were reduced in ALK5CKO femurs. DAPI, 4,6-diamidino-2-phenylindole. Arrowheads, bone collar. Bar, 100 μm.
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ences in proliferation and differentiation between wild type and
Alk5ﬂox/ﬂox cells in the absence or presence of tamoxifen (Supple-mental Fig. S8). These results indicate that tamoxifen affects cellular
activities speciﬁc to Alk5ﬂox/ﬂox; CreER™/+cells, but not to CreER-
negative Alk5ﬂox/ﬂox and wild type cells. Thus, TGF-β signaling is
Fig. 5. Tamoxifen-induced ALK5 inactivation results in the inhibition of proliferation and differentiation of primary calvarial cells. Calvarial cells were prepared from newborn ALK5/
Cre-ER mice. (A) The number of cells was counted 3 days after treatment with ethanol (control) or tamoxifen. Inactivation of ALK5 resulted in growth inhibition of calvarial cells. (B)
Representative microscopic pictures of X-gal/ALP-staining of primary calvarial cell cultures in the absence or presence of tamoxifen at day 3 after osteoinduction. Overall views of
ALP-stained wells are shown in the insets. X-gal-positive cells showed little ALP activity. (C) Representative pictures of Alizarin Red S staining of primary calvarial cells on day 17 after
osteoinduction (left). Quantiﬁcation of the staining is shown (right). Inactivation of ALK5 resulted in reduced mineralization of calvarial cells. Note that TGF-β2 (1 ng/mL) inhibited
mineralization of normal calvarial cells, but not of ALK5-deﬁcient cells. Data represent means ± SD. (D) Schematic outlines of the experimental design.
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These combined results suggest that ALK5 positively regulates
proliferation and early differentiation of osteoblasts in calvarial cell
culture.
ALK5 is required for the commitment of progenitor cell differentiation to
the osteoblast lineage
While tamoxifen inhibited osteogenic differentiation of ALK5/
Cre-ER calvarial cells, we noticed that droplet-containing cells
became visible at about 1 week after tamoxifen treatment and
became prominent throughout the culture. The droplets were
stained with the lipophilic and ﬂuorogenic dye, Nile Red, indicating
that the calvarial culture contained adipocytes (Fig. 6A). To
investigate the relationship between adipocytogenesis and ALK5inactivation, double staining with X-gal was performed, followed by
staining with another lipophilic dye, Oil Red O. Many Oil Red O-
positive cells were also positive for X-gal staining (Fig. 6B). These
data indicated that inactivation of ALK5 caused differentiation of
calvarial cells to adipocytes, instead of osteoblasts. Using Nile Red, a
method was established for quantifying Nile Red-positive areas
under ﬂuorescence microscopy, as described in Materials and
methods. Even in the absence of tamoxifen, small areas were
positive for Nile Red. In the presence of tamoxifen, the positive
areas dramatically increased (Fig. 6C). On the other hand, addition
of TGF-β2 completely blocked adipocytogenesis in the absence of
tamoxifen (Fig. 6C). The inhibition of adipocytogenesis by TGF-β2
was also observed even in the presence of tamoxifen (Fig. 6C). This
inhibitory effect likely occurred because the level of tamoxifen-
mediated Alk5 deletion was not 100%. These data were consistent
Fig. 6. Tamoxifen-induced ALK5 inactivation increased adipocytogenesis in primary calvarial cell cultures. (A) Representative light and ﬂuorescent microscopic images of Nile Red
(green signal) staining of primary calvarial cell cultures in the absence or presence of tamoxifen at day 18 after osteoinduction. Droplets observed in light microscopy (left, black
arrows) were positive for Nile Red lipophilic ﬂuorescent dye (right, white arrows). (B) Microscopic pictures of X-gal/Oil Red O-staining of primary calvarial cell cultures in the
absence or presence of tamoxifen at day 20 after osteoinduction. Note that many Oil Red O-positive cells were also positive for X-gal staining. (C) Adipocytogenesis was quantiﬁed by
the Nile Red-positive area as described in Materials and methods. Data represent means±SD. Inactivation of ALK5 resulted in enhanced adipocytogenesis of calvarial cells. (D) Real-
time quantitative RT-PCR for the osteoblast-speciﬁc osterix and adipocyte-speciﬁc differentiationmarkers PPARγ and C/EBPα. cDNA, prepared usingmRNA from calvarial cells on the
6th day of the osteogenic culture, was subjected to real-time quantitative PCR. Osteogenic marker expressionwas downregulatedwhile adipocytemarker expressionwas upregulated
in the presence of tamoxifen.
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shown).
Expression of osterix mRNA as an osteoblast marker and of PPARγ
and C/EBPα mRNAs as adipocyte markers in calvarial cells were
examined on the 6th day under the osteogenic condition by real-time
quantitative RT-PCR. Consistent with the immunohistochemistry
results for osterix observed in vivo (Fig. 4C), the expression of osterix
mRNA was signiﬁcantly downregulated in the tamoxifen-treated
calvarial cells (Fig. 6D). On the other hand, expression of PPARγ and
C/EBPα mRNA was markedly upregulated in the tamoxifen-treated
cells (Fig. 6D). Tamoxifen treatment did not affect adipocytogenesis of
Cre-negative Alk5ﬂox/ﬂox control calvarial cells (Supplemental Fig. S9).
Taken together, these results suggest that TGF-β signaling promotes
the commitment of progenitor cells to the osteoblast lineage and
inhibits adipocytogenesis through ALK5.
ALK5 regulates osteoblast lineage, proliferation, and differentiation
through selective Smad2/3 and MAPKs pathways
To examine the regulatory mechanism of calvarial cell proliferation
and differentiation, the MAPK and Smad2/3 pathways, two majordownstream pathways of TGF-β signaling, were analyzed. First, to
examine the activation status of TGF-β signaling pathways during
osteoblastic differentiation of calvarial cells, the expression level of
ALK5 protein and the phosphorylation level of Smad2, as a
representative direct substrate for ALK5, were analyzed by Western
blotting. Osteogenic induction increased ALK5 protein expression at
3 days after induction, but ALK5 expression was gradually decreased
thereafter (Fig. 7A). Since anti-phospho-ALK5 antibody is not
available and Smad2 is a substrate of phosphorylation by ALK5, we
examined the phosphorylation level of Smad2 with anti-phospho-
Smad2. The phosphorylation level of Smad2 was transiently induced
and then decreased as differentiation proceeded (Fig. 7B), in a similar
pattern to that seen for ALK5 expression. These results suggest that
ALK5 expression and activity were diminished, as well as Smad2/3, as
direct downstream molecules of ALK5 became inactive with osteo-
blast maturation.
Next, the effect of ALK5 inactivation on phosphorylation of JNK,
Erk1/2, and p38 was examined. At the 3rd day after osteoinduction,
the phosphorylation levels of JNK, Erk1/2, and p38 were decreased in
the presence of tamoxifen (Fig. 7C). Tamoxifen did not affect the
activity of these signaling molecules in Cre-negative Alk5ﬂox/ﬂox
Fig. 7. MAPK and Smad signaling during osteogenic differentiation of primary calvarial
cells. (A) Expression level of ALK5 protein during normal primary calvarial cell
differentiation. Cultures of primary calvarial cells from control mice were incubated in
osteoinduction medium and cell lysates were prepared at the indicated times. α-
Tubulin was used as a loading control in this experiment. ALK5 protein expression
diminished with osteoblast maturation. (B) Reactivity of primary calvarial cells to TGF-
β2 during differentiation. The primary calvarial cells cultured in osteoinduction
medium were incubated with TGF-β2 for 1 h at various time points as indicated.
Lysates were analyzed for phospho-Smad2 by Western blot analysis. Activation of
Smad2 by TGF-β2 decreased during maturation of calvarial cells. (C) Effects of ALK5
inactivation on activation of JNK, Erk1/2, and p38. Primary calvarial cells were grown
for 3 days in osteoinduction medium, in the absence or presence of tamoxifen, and
lysates were prepared and subjected to Western blot analysis. Inactivation of ALK5
resulted in decreased activity of MAPKs. Ctrl, control; Tam, tamoxifen.
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early stage of osteoblast differentiation, MAPK pathways are activated
through ALK5.
Several inhibitors of MAPK and Smad pathways were tested to
examine the involvement of these signaling pathways in control
calvarial cells. SP600125 and SIS3, which are JNK and Smad3 inhibitors
(Jinnin et al., 2006), respectively, signiﬁcantly inhibited proliferation
of normal calvarial cells (Fig. 8A). In contrast, U0126 and SB203580,
which are Erk1/2 and p38 inhibitors, respectively, had little effect on
calvarial cell proliferation (Fig. 8A). In order to examine the
involvement of the JNK pathway in proliferation of perichondrial
cells, primordial metatarsal cartilage was isolated from E15.5 ALK5CKO
and control mice, and explant organ culture experiments were carried
out. Consistent with the result of BrdU incorporation (Fig. 4A), there
were fewer BrdU-positive cells in the perichondrium of ALK5CKO
metatarsals than in the control explants (Fig. 8B). Addition of TGF-β2
increased BrdU-positive cells in control metatarsals, whereas TGF-β2
had little effect on BrdU incorporation into the perichondrium of
ALK5CKO explants (Fig. 8B). The involvement of the JNK pathway in
metatarsal explant cultures was also examined. At the 4th day ofcontrol metatarsal culture, phosphorylation of JNK was substantially
induced in the perichondrium in the presence of TGF-β2, compared
with that in the absence of TGF-β2. On the other hand, in ALK5CKO
metatarsal culture, phosphorylation of JNK was low regardless of the
absence or presence of TGF-β2 (Fig. 8C). TGF-β signaling therefore
positively regulated progenitor cell proliferation, in part through the
JNK and Smad2/3 pathways.
The effect of MAPKs and Smad3 inhibitors on ALP activity, an early
osteoblast differentiation marker, in calvarial cells was also examined.
In the absence of tamoxifen, treatment with SB203580 and SIS3
inhibited ALP activity (Fig. 8D), but inhibitors for Erk1/2 and JNK did
not (data not shown). Tamoxifen did not affect the inhibitory activities
of SB203580 and SIS3 in ALP activity of Cre-negative Alk5ﬂox/ﬂox
control calvarial cells (Supplemental Fig. S11). Consistent with the
ALP-staining results (Fig. 5B), in the presence of tamoxifen, ALP
activity was inhibited. Treatment with SB203580 further reduced
ALP activity, while SIS3 did not have any additive inhibitory effects
(Fig. 8D). Thus, in the early differentiation phase, TGF-β signaling
appears to control osteoblast differentiation, in part through the p38
and Smad2/3 pathways.
The role of the MAPKs and Smad3 pathways in adipocytogenesis of
normal calvarial cells was also examined. In contrast to the ALP
inhibition results, SB203580 and SIS3 substantially promoted adipo-
cytogenesis, but SP600125 and U0126 had negligible effect on
adipocytogenesis (Fig. 8E). As shown in Fig. 6C, even low concentra-
tions of TGF-β2 (0.1 ng/mL) almost completely blocked adipocyto-
genesis of calvarial cells (Fig. 8F). However, simultaneous treatment
with SB203580 and SIS3 partially blocked the inhibitory effect of TGF-
β2 (Fig. 8F). These results suggest that TGF-β signaling suppresses
adipocytogenesis, in part through the p38 and Smad2/3 pathways.
Taken together with the ALP inhibition data, the data presented here
suggest that TGF-β signaling positively and negatively regulates
osteoblastogenesis and adipocytogenesis, respectively, in part through
the p38 and Smad2/3 pathways.
Discussion
Despite many investigations, the role of TGF-β signaling in
endochondral bone formation remains controversial, as often oppos-
ing results have been reported (Dunker and Krieglstein, 2000).
Although many studies suggest the importance of TGF-β signaling in
skeletogenesis, its in vivo role is not yet fully understood. ALK5 is the
target receptor for a broad range of TGF-β signaling pathways. In this
report, we created ALK5CKO mice, in which ALK5 was conditionally
inactivated in skeletal progenitors at the early stage of bone
development, in order to address the physiological role of TGF-β
signaling in skeletogenesis. TGF-β signaling appears to be critical for
perichondrium formation, progenitor cell commitment, osteoblast
proliferation, and early differentiation, through selective Smad2/3
and MAPKs signaling pathways.
Skeletal defects in ALK5CKO mice
Conditional ALK5 inactivation by Dermo1-Cre overcame early
embryonic lethality and allowed for survival until birth. In ALK5CKO
mice, both intramembranous and endochondral ossiﬁcation were
impaired. In this study, severe bone formation defects in ALK5CKO
mice during embryogenesis were identiﬁed, including short-limbed
dwarﬁsm, less mineralization, and defects in bone integrity and
isotropy. These abnormalities detected in the ALK5CKO mice correlate
mostly with the expression pattern of ALK5 in developing limbs and
calvaria. In mouse embryos, both ALK5 and Dermo1-Cre were
expressed in developing articular cartilage, ligaments, and synovium
(Supplemental Fig. S2). One of the striking pathological changes
observed in ALK5CKO mice was the abnormal formation of the
perichondrium. Immunoﬂuorescent staining in developing limbs
Fig. 8. TGF-β signaling pathways in proliferation and differentiation of primary calvarial cells and metatarsal explants. (A) Effects of MAPKs and Smad3 inhibitors on normal primary
calvarial cell proliferation. Inhibitors for JNK and Smad3, but not for Erk1/2 and p38, reduced proliferation. (B) Proliferation of control and ALK5CKO metatarsal organ culturewith and
without TGF-β2. Safranin-O staining (top) and BrdU staining (bottom) of metatarsal rudiments at the 4th day after treatment. Safranin-O staining shows a thin perichondrial layer
compared with the control layer. (Right) The number of BrdU-labeled cells in the perichondrium was quantiﬁed. BrdU-positive cells in the ALK5CKO perichondrium were reduced.
TGF-β2 increased BrdU-positive cell numbers in the control perichondrium, but did not affect the ALK5CKO perichondrium. Black bars, without TGF-β2; open bars, with TGF-β2. (C)
Immunostaining for phospho-JNK in metatarsal rudiments using the same samples used for panel B at day 4 after TGF-β2 treatment. The expression of phospho-JNK was detected in
the control perichondrium and its expression level was increased in the presence of TGF-β2. There was little phospho-JNK expression in the ALK5CKO perichondriumwith or without
TGF-β2. (D) Effect of p38 and Smad3 inhibitors on ALP activity of primary calvarial cells at day 3 after osteoinduction. Tamoxifen was added one day before osteoinduction, as
illustrated in Fig. 5D. In tamoxifen-induced ALK5-deﬁcient calvarial cells, ALP activity was reduced. Treatment with the Smad3 inhibitor, SIS3, did not change ALP activity, but the p38
inhibitor, SB203580, further reduced the activity. (E) Effects of MAPKs and Smad3 inhibitors on adipocytogenesis of normal primary calvarial cells. Adipocytogenesis was quantiﬁed
by Nile Red-positive area. SIS3 and SB203580, but not the JNK inhibitor SP600125 or Erk1/2 inhibitor U0126 promoted calvarial cell differentiation to adipocytes. (F) Additive effects
of p38 and Smad3 inhibitors on adipocytogenesis. Normal primary calvarial cells were cultured in osteoinductionmedium containing either SB203580 or SIS3, or both in the presence
of TGF-β2. DMSO, control; SP600125, JNK inhibitor; U0126, Erk1/2 inhibitor; SB203580, p38 inhibitor; SIS3, Samd3 inhibitor.
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drium and in a unique, thin chondrocyte layer located peripherally in
the cartilage adjacent to the ALK5-expressing perichondrial layer
(Figs. 3F, F′ and Supplemental Fig. S3). ALK5 expression in
chondrocytes of the growth plate has been reported (Horner et al.,
1998; Iseki et al., 1995; Sakou et al., 1999). We also observed that
ALK5 was expressed in resting and hypertrophic chondrocytes. The
expression of ALK5 in these chondrocytes was weaker than that in
the perichondrium and the unique chondrocyte layer.
The perichondrium is implicated in regulating the growth of the
long bone (Alvarez et al., 2001; Alvarez et al., 2002; Di Nino et al.,
2001), and when the perichondrial layer is enzymatically removed,TGF-β loses its power to regulate metatarsal growth (Alvarez et al.,
2001). These results suggest the importance of TGF-β signaling in the
perichondrium in long bone development. Newborn mice with a
chondrocyte-speciﬁc conditional deletion of Tgfbr2 using Col2a1-Cre
have normal bone length and mineralization in limbs and joints (Bafﬁ
et al., 2004). In contrast to Dermo1-Cre expression, Col2a1-Cre is
expressed strongly in differentiating chondrocytes and its expression
in the perichondrium is low (Ovchinnikov et al., 2000). Differences in
Cre expression stages and levels may account for the phenotypic
differences in these two mouse models.
In the ALK5CKO mice, the proliferation activity and differentiation
of perichondrial cells were reduced and a thin perichondrial layer was
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the perichondrium in metatarsal rudiment explants and the primary
calvarial cells showed reduced proliferation activity when ALK5 was
inactivated (Figs. 5A, 8B). The perichondrial cells in the ossiﬁcation
groove of Ranvier have the highest proliferation activity (Shapiro
et al., 1977) and in our study expressed ALK5 strongly (Fig. 1). Thus,
TGF-β signaling is likely responsible for the high proliferation
activity. Furthermore, TGF-β signaling is required for the formation
of the perichondrium. The abnormal perichondrium of ALK5CKO mice
may cause ectopic cartilaginous protrusions. In addition, the unique
ALK5-expressing chondrocyte layer located in the peripheral carti-
lage may contribute to preventing ectopic protrusion in wild type
limbs. These cells express aggrecan and Sox9, chondrocyte markers
(Fig. 3 and Supplemental Fig. S3), similar to chondrocytes in other
parts of cartilage. However, these cells' strong ALK5 expression is
unique and they are a previously unidentiﬁed chondrocyte popula-
tion. TGF-β signaling in these cells may negatively regulate
proliferation and have speciﬁc cellular activity that limits the lateral
expansion of the cartilage. Without TGF-β signaling, the cells lose
these activities and allow abnormal lateral expansion through the
ossiﬁcation groove of Ranvier. The results of the present study
suggest that TGF-β signaling regulates perichondrium formation and
is essential for maintaining the proper integrity, size, and shape of
cartilage during the development of the growth plate.
It has been demonstrated that TGFβRII is expressed in the articular
cartilage of the interphalangeal joints (Spagnoli et al., 2007) and in the
perichondrium (Horner et al., 1998). Germline null mutations of
TGFβRII and ALK5 in mice result in early embryonic lethality around
E10.5 because of defects in hematopoiesis and vasculogenesis before
skeletal elements are formed (Larsson et al., 2001; Oshima et al.,
1996). This suggests that TGFβRII and ALK5 form a heteromeric
complex and share their roles in hematopoiesis and vasculogenesis.
There are similarities between the abnormal phenotypes in ALK5CKO
mice and Prx1-Cre-mediated Tgfbr2 conditional knockout mice. Both
Dermo1-Cre and Prx1-Cre are expressed in mesenchymal progenitors,
and those mice exhibit short-limbed dwarﬁsm, abnormal sternums,
and defects in joints (Seo and Serra, 2007; Spagnoli et al., 2007),
suggesting that TGFβRII and ALK5 also form a complex in mesench-
ymal progenitor cells. However, there are differences between Prx1-
Cre Tgfbr2 and ALK5CKO mice. Prx1-Cre Tgfbr2 mice develop fusion of
the joints of the phalanges, while ALK5CKO mice had normal phalange
joints but developed partial fusion of the knee joints. In addition, there
are some differences with regard to the causes of the short long bones
in these mutant mice. In Prx1-Cre Tgfbr2mice, the short length of the
long bones is primarily due to a decrease in chondrocyte proliferation
and a delay in late hypertrophic differentiation. In contrast, there was
no substantial decrease in chondrocyte proliferation and differentia-
tion in ALK5CKO growth plates. The alteration of the long bone length
in ALK5CKO mice is mainly due to a decrease in the proliferation and
differentiation of the perichondrium. During development, Prx1-Cre is
expressed earlier than Dermo1-Cre in mesenchymal progenitors
(Rodda and McMahon, 2006). It is also possible that the expression
levels of Dermo1-Cre and Prx1-Cre may differ in mesenchyme
progenitors, perichondrial cells and chondrocytes. These differences
may contribute to the phenotypic difference in these mouse models. It
has been reported that ALK5 can form a complex with other type II
receptors such as ACTRII (Andersson et al., 2006; Rebbapragada et al.,
2003; Tsuchida et al., 2008; Wu et al., 2003). Therefore, it is possible
that ALK5 may exert its activity independent of TGFβRII in certain
tissues and developmental stages. Indeed, this may also explain the
differences in these mice.
For ligand speciﬁcity, any TGF-β (i.e., TGF-β1, -β2, and -β3) can
bind to the TGFβRII/ALK5 receptor complex. Although TGF-β1 is the
most abundant among the three TGF-βs in the bonematrix, all TGF-βs
are expressed in the perichondrium (Millan et al., 1991; Pelton et al.,
1991). TGF-β1 knockout mice are born normally but develop amultifocal inﬂammatory disease that leads to death by weaning age
(Kulkarni et al., 1993). In contrast, TGF-β2 and -β3 double knockout
mice develop herniation of visceral organs (Dünker and Krieglstein,
2002), which is similar to our ALK5CKO mice. Therefore, it can be
asserted that TGF-β2 and -β3 may be major ligands for ALK5.
TGF-β signaling promotes osteoblast proliferation through
Smad-dependent and Smad-independent pathways
Smad2/3 are known as direct substrates for ALK5. Consistent
with our results from ALK5CKO growth plates (Fig. 4A) and explants
(Fig. 8B), the Smad3-speciﬁc inhibitor SIS3 (Jinnin et al., 2006) was
found to inhibit proliferation of normal primary calvarial cells (Fig.
8A). In ALK5-deﬁcient calvarial cells, phosphorylation of Smad2 was
not induced, even in the presence of TGF-β (data not shown). In
MAPK pathways, mediators between the TGF-β receptor complex and
MAPK kinase kinases (MAPKKKs) have not yet been established.
However, considerable evidence suggests that TGF-β signaling is able
to initiate MAPK pathways. The results from our metatarsal explants
suggest that TGF-β signaling regulates osteoblast proliferation, at
least in part, through JNK. JNK was originally identiﬁed as a stress-
activated protein kinase, but it is now known to regulate diverse
cellular processes, including osteoblast proliferation (Hipskind and
Bilbe, 1998). In addition, JNK activation by TGF-β phosphorylates
Smad3 and facilitates Smad-dependent transcriptional activity (Engel
et al., 1999). Therefore, it is likely that the JNK and Smad2/3 pathways
cooperatively regulate osteoblast proliferation.
TGF-β signaling is required for early, but not late,
osteoblast differentiation
It was unclear whether TGF-β signaling promotes or inhibits
osteoblast differentiation in vivo. Similar to the different effects of
TGF-β on osteoblast proliferation in culture (Antosz et al., 1989), the
effects of TGF-β on osteoblast differentiation in vitro are often
controversial, primarily because they are affected by culture condi-
tions. We found that the expression of the early osteoblast
differentiation markers, runx2, osterix, and ALP, was reduced when
ALK5 was inactivated at the early stage by Dermo1-Cre in vivo (Figs.
4C, D) and tamoxifen-inducible Cre in vitro (Figs. 5B, D, 8D). Therefore,
we conclude that TGF-β signaling regulates early differentiation of
osteoblasts through ALK5.
Smad2 and Smad3 are activated by TGF-β and Activin, whereas
Smad1, Smad5, and Smad8 are activated by BMP signaling. BMP
signaling induces osteoblast differentiation, and shares a common
partner, Smad4, with TGF-β signaling. Pharmacological inhibition of
TGF-β signaling may cause an increase in the pool of Smad4 available
for BMP signaling (Inman et al., 2002). Therefore, we performed
immunostaining of phospho-Smad1/5/8 in order to examinewhether
ALK5 inactivation causes an increase in BMP signaling. We found that
the expression level of phospho-Smad1/5/8 in the perichondrium of
ALK5CKO embryos was similar to that in control embryos (Supple-
mental Fig. S7). In normal growth plates, ALK5 expression in the
perichondrium decreased when cells differentiated into mature
osteoblasts (Figs. 1, 3). During differentiation of calvarial cells in
culture, ALK5 expression and activation of Smad2 were initially
induced, but later gradually decreased (Figs. 7A, B). These expression
patterns suggest that ALK5 is not necessary for the late differentiation
of osteoblasts. Indeed, no defects were observed in endochondral
ossiﬁcation in Col1a1-Cre-mediated ALK5 knockout mice, in which
Col1a1-Cre was expressed in differentiated osteoblasts (data not
shown). In addition, no mineralization defects were found in ALK5/
Cre-ER calvarial cells when ALK5 inactivation was induced by the
addition of tamoxifen, on or after the 4th day of osteoinduction (data
not shown). TGF-β2 did not inhibit mineralization of ALK5-deﬁcient
calvarial cells (Fig. 5C), suggesting that differentiating osteoblasts
337T. Matsunobu et al. / Developmental Biology 332 (2009) 325–338become mature independent of TGF-β signaling. These data indicate
that TGF-β signaling is not required for the maturation of osteoblasts.
It has been reported that the expression level of TGF-β receptors
decreases during retinoic acid-induced osteoblastic differentiation of
multipotent mesenchymal cells (Gazit et al., 1993) and that TGF-β
binding to the receptors is reduced in differentiated osteogenic cells
(Takeuchi et al., 1996). Together with the results of previous reports,
our results suggest that the TGF-β signaling is attenuated in the
maturation stage of osteoblast differentiation, and that sustained
activation of TGF-β signaling may perturb osteoblast maturation.
TGF-β signaling regulates the fate of osteoprogenitors
We found that some ALK5-deﬁcient calvarial cells differentiated
into adipocytes under the osteogenic induction condition (Fig. 6).
Addition of TGF-β completely abolished adipocytogenesis of control
calvarial cells. These results suggest that TGF-β signaling promotes the
commitment of progenitor cells to the osteoblast lineage. It has been
reported that some calvarial cells differentiate into adipocytes
(Bellows and Heersche, 2001; Sabatakos et al., 2000). About 95% of
fetal rat calvarial cells are committed to the osteoblastic cell lineage
and the rest (∼5%) are common osteoblast/adipocyte progenitors
(Bellows and Heersche, 2001). By FACS analysis, this study found that
Nile Red-positive cells constituted, at most, 4% of the primary calvarial
cells (data not shown), similar to a previous report (Bellows and
Heersche, 2001). A mouse study for the comparison of adipogenic and
osteogenic abilities of bone marrow stem cells isolated from aged and
young mice showed that the aged cells expressed fewer TGF-β signal
molecules than did the young cells, and these differentiated into
adipocytes rather than to osteoblasts (Moerman et al., 2004).
Considering these results, we conclude that TGF-β signaling regulates
commitment of progenitor cells to the osteoblast lineage through
ALK5.
Signaling pathways in osteoblast differentiation and cell
fate commitment
During calvarial cell differentiation, JNK, ErK1/2, and p38 were
activated (Supplemental Fig. S6). The activation of these signaling
molecules was reduced in tamoxifen-induced ALK5-deﬁcient calvarial
cells (Fig. 7C). Inhibitors for Smad3 and p38 inhibited early osteoblast
differentiation (Fig. 8D). JNK inhibitor did not affect differentiation
(data not shown). This may be because JNK is involved in other
cellular events.
Smad3 inhibitor also inhibited early differentiation (Fig. 8D).
Smad2 was activated during early osteoinduction (Fig. 7B). These
results suggest that Smad2/3 and p38, but not JNK, regulate osteoblast
differentiation. Phenotypes of Smad3 mutant mice vary depending
upon which exon of the Smad3 gene is targeted. Mice with Smad3
mutations in exon 1 or 2 are viable while a Smad3 mutation in exon 8
is lethal between 1 and 8 months of age (Borton et al., 2001; Datto et
al., 1999; Yang et al., 1999; Zhu et al., 1998). Smad3 is known to
physically interact with many signaling molecules such as runx2, β-
catenin, and vitamin D receptor (Alliston et al., 2001; Li et al., 2006;
Yanagi et al., 1999). Further investigation into the regulatory
mechanism of osteoblast differentiation through Smad3 is required.
In contrast to osteoblast differentiation, inhibitors of Smad3 and
p38 promoted differentiation of calvarial progenitor cells into
adipocytes (Fig. 8E). JNK and Erk1/2 inhibitors did not affect
adipocytogenesis. It has been reported that TGF-β signaling inhibits
adipocytogenesis by inhibition of C/EBP via physical interaction with
Smad3. Marrow stem cells isolated from Smad3-null mice were
resistant to hypoxia-mediated inhibition of adipocyte differentiation.
The inhibitory role of p38 in adipocytogenesis was also found using
dietary and genetically obese mice and p38-null ES cells (Aouadi et al.,
2006). These previous results are consistent with our ﬁndings incalvarial cells. Taken together, Smad3 and p38 pathways suppress
adipocyte differentiation of calvarial progenitor cells in an opposite
manner to that seen for osteoblast differentiation. Our data suggest
that TGF-β signaling regulates the commitment of calvarial cell
progenitors to the osteoblast lineage.
Although TGF-β signaling is attenuated and is likely dispensable
for osteoblast maturation, the JNK, Erk1/2, and p38 pathways
remained active throughout osteoblast differentiation (Supplemental
Fig. S6). p38 has been implicated in BMP-induced osteoblast
differentiation (Guicheux et al., 2003), while FGF and BMP signaling
are known to regulate osteoblast differentiation via MAPK pathways
(Xiao et al., 2002a; Xiao et al., 2002b). This suggests that the sustained
activity of these signalingmolecules is regulated by other extracellular
signaling molecules, such as FGF and BMP, during the late differentia-
tion stage, when TGF-β signaling is switched off.
In conclusion, the present study reveals the critical roles of TGF-β
signaling in joint and perichondrium formation, in progenitor
commitment, and in osteoblast proliferation and early differentiation,
through the operation of selective Smad-dependent and -independent
pathways, during fetal bone development.
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